A comparative genetic approach for the investigation of ageing grey horse melanoma

Journal of Animal Breeding and Genetics

Volumn 117, Issue 2, 2000, Pages 73-82

  Rieder, S ^a   Stricker, C ^a   Joerg, H ^a   Dummer, R ^b   Stranzinger, G ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

EID: 0347999670     PISSN: 09312668     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0388.2000x.00245.x     Document Type: Article

References (30)

1. ADEMA, G. J.; BAKKER, A. B. H.; DE BOER, A. J.; HOHENSTEIN, P.; FIGDOR, C. G., 1996: pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL. Br. J. Cancer 73: 1044-1048.
2. ADEMA, G. J.; DE BOER, A. J.; VOGEL, A. M.; LOENEN, W. A. M.; FIGDOR, C. G., 1994: Molecular characterization of the melanocyte lineage-specific antigen gp100. J. Biol. Chem. 269:20126-20133.
3. BARSH, G. S., 1996: The genetics of pigmentation: from fancy genes to complex traits. Trends Genet. 12: 299-305.
4. BOWLING, A. T.; BREEN, M.; CHOWDHARY, B. P.; HIROTA, K.; LEAR, T.; MILLON, L. V.; DE PONCE LEON, F. A.; RAUDSEPP, T.; STRANZINGER, G., 1997: International system for cytogenetic nomenclature of the domestic horse. Chromosome Res. 5: 433-443.
5. CANNON-ALBRIGHT, L. A.; GOLDGAR, D. E.; MEYER, L. J.; LEWIS, C. M.; ANDERSON, D. E.; FOUNTAIN, J. W.; HEGI, M. E.; WISEMAN, R. W.; PETTY, E. M.; BALE, A. E.; OLOPADE, O. I.; DIAZ, M. O.; KWIATKOWSKI, D. J.; PIEPKORN, M. W.; ZONE, J. J.; SKOLNICK, M. H., 1992: Assignment of a locus for familial melanoma MLM, to chromosome 9p13-p22. Science 258: 1148-1152.
6. CANNON-ALBRIGHT, L. A.; GOLDGAR, D. E.; NEUHAUSEN, S.; GRUIS, N. A.; ANDERSON, D. E.; LEWIS, C. M.; JOST, M.; TRAN, T. D.; NYGUEN, K.; KAMB, A.; WEAVER-FELDHAUS, J.; MEYER, L. J.; ZONE, J. J.; SKOLNICK, M. H., 1994: Localization of the 9p melanoma susceptibility locus to a 2cM region between D9S736 and D9S171. Genomics 23: 265-268.
7. CANNON-ALBRIGHT, L. A.; KAMB, A.; SKOLNICK, M., 1996: A review of inherited predisposition to melanoma. Semin. Oncol. 23: 667-672.
8. DEVEREUX, J.; HAEBERLI, P.; SMITHIES, O., 1984: A comprehensive set of sequence analysis programs for the VAX. Nucl. Acids Res. 1: 387-395.
9. FOLEY, G. L.; VALENTINE, B. A.; KINCAID, A. L., 1991: Congenital and acquired melanocytomas (benign melanomas) in eighteen young horses. Vet. Pathol. 28: 363-369.
10. GEBHART, W.; NIEBAUER, G. W., 1977: Beziehungen zwischen Pigmentschwund und Melanomatose am Beispiel des Lipizzanerschimmels. Arch, für Dermatol. Res. 259: 29-42.
11. GUERIN, G.; BAILEY, E.; BERNOCO, D.; ANDERSON, I.; ANTCZAK, D. F.; BELL, K.; BINNS, M. M.; BOWLING, A. T.; BRANDON, R.; CHOLEWINSKI, G.; COTHRAN, E. G.; ELLEGREN, H.; FÖRSTER, M.; GODARD, S.; HORIN, P.; KETCHUM, M.; LINDGREN, G.; MCPARTLAN, H.; MÉRIAUX, J. C.; MICKELSON, J. R.; MILLON, L. V.; MURRAY, J.; NEAU, A.; ROED, K.; SANDBERG, K.; SHIUE, Y. L.; SKOW, L. C.; STOTT, M.; SWINBURNE, J.; VALBERG, S. J.; VAN HAERINGEN, H.; VAN HAERINGEN, W. A.; ZIEGLE, J., 1999: Report of the International Equine Gene Mapping Workshop: male linkage map. Anim. Genet. 30: 341-354.
12. HALUSKA, F. G.; HODI, S. F., 1998: Molecular genetics of familial cutaneous melanoma. J. Clin. Oncol. 16: 670-682.
13. HASSTEDT, S. J., 1994: Pedigree Analysis Package. Revision 4.0. Department of Human Genetics, University of Utah, Salt Lake City.
14. B-w) is a dominant mutation causing reduced hair pigmentation owing to a chromosomal inversion. Mammalian Genome 9: 469-471.
15. JOHNSON, R.; JACKSON, I. J., 1992: Light is a dominant mouse mutation resulting in premature cell death. Nature Genet. 1: 226-229.
16. KWON, B. S.; HALABAN, R.; PONNAZHAGAN, S.; KIM, K.; CHINTAMANENI, C.; BENNETT, D.; PICKARD, R. T., 1995: Mouse silver mutation is caused by a single base insertion in the putative cytoplasmic domain of Pmel17. Nucl. Acids Res. 23: 154-158.
17. LEE, Z. H.; HOU, L.; MOELLMANN, G.; KUKLINSKA, E.; ANTOL, K.; FRASER, M.; HALABAN, R.; KWON, B. S., 1996: Characterization and subcellular localization of human Pmel 17/silver, a 100-kDa (Pre) melanosomal membrane protein associated with 5,6,-dihydroxyindole-2-carboxylic acid (DHICA) converting activity. J. Invest. Dermatol. 106: 605-610.
18. NESTLÉ, F. O.; ALIJAGIC, S.; GILLIET, M.; SUN, Y.; GRABBE, S.; DUMMER, R.; BURG, G.; SCHADENDORF, D., 1998: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med. 4: 328-332.
19. OHMURO, K.; OKADA, K.; SATOH, A.; MURAKAMI, K.; SATAKE, S.; ASAHINA, M.; NUMAKUNAI, S.; OHSHIMA, K., 1993: Morphogenesis of compound melanosomes in melanoma cells of a gray horse. J. Vet. Med. Sci. 55: 677-680.
20. RAUDSEPP, T.; FRÖNICKE, L.; SCHERTHAN, H.; GUSTAVSSON, I.; CHOWDHARY, B., 1996: Zoo-FISH delineates conserved chromosomal segments in horse and man. Chromosome Res. 4: 218-225.
21. RIEDER, S., 1999: Angewandte vergleichende Genetik am Beispiel des Melanoms beim Pferd. PhD Thesis Swiss Federal Institute of Technology, No. 13071.
22. RODRIGUEZ, M.; GARCIA-BARONA, V.; PENA, L.; CASTANO, M.; RODRIGUEZ, A., 1997: Grey horse melanotic condition: a pigmentary disorder. J. Equine Vet. Sci. 17: 677-681.
23. ROSENBERG, S. A., 1997: Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18: 175-182.
24. ROSENBERG, S. A.; YANG, J. C.; SCHWARTZENTRUBER, D. J.; HWU, P.; MARINCOLA, F. M.; TOPALIAN, S. L.; RESTIFO, N. P.; DUDLEY, M. E.; SCHWARZ, S. L.; SPIESS, P. J.; WUNDERLICH, J. R.; PARKHURST, M. R.; KAWAKAMI, Y.; SEIPP, C. A.; EINHORN, J. H.; WHITE, D. E., 1998: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med.. 4: 321-327.
25. SAMBROOK, J.; FRITSCH, E. F.; MANIATIS, T., 1989: Molecular Cloning. A Laboratory Manual, I-III. Sc. Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. SEARLE, A. G., 1968: Comparative Genetics of Coat Colour in Mammals. Logos Press, London.
27. SERRANO, M.; HANNON, G. J.; BEACH, D., 1993: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
28. SHIUE, Y. L.; BICKEL, L. A.; CAETANO, A. R.; MILLON, L. V.; CLARK, R. S.; EGGLESTON, M. L.; MICHELMORE, R.; BAILEY, E.; GUÉRIN, G.; GODARD, S.; MICKELSON, J. R.; VALBERG, S. J.; MURRAY, J. D.; BOWLING, A. T., 1999: A synteny map of the horse genome comprised of 240 microsatellite and RAPD markers. Anim. Genet. 30: 1-9.
29. VALENTINE, B. A., 1995: Equine melanocytic tumors: a retrospective study of 53 horses (1988-91). J. Vet. Intern. Med. 9: 291-297.
30. WAGNER, S. N.; WAGNER, C.; SCHULTEWOLTER, T.; GOOS, M., 1997: Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy. Cancer Immunol.. Immunother. 44: 239-247.